Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of Erythrocytes01:27

Disorders of Erythrocytes

2.9K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.9K
Disorders of Hemostasis01:24

Disorders of Hemostasis

2.8K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.8K
Disorders of Leukocytes01:27

Disorders of Leukocytes

2.5K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
2.5K
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

12.1K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
12.1K
Erythropoiesis01:14

Erythropoiesis

7.0K
Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
7.0K
Erythropoiesis01:14

Erythropoiesis

4.2K
4.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quality Improvement Intervention for Reduction of Redundant Testing.

Academic pathology·2017
Same author

Hematologic Disorders: Blood Transfusion Products.

FP essentials·2015
Same author

Hematologic Disorders: Bone Marrow Failure.

FP essentials·2015
Same author

Hematologic Disorders: Sickle Cell Disease.

FP essentials·2015
Same author

Chondrosarcoma of the tongue: a case report and a review of the literature.

The Laryngoscope·2012
Same author

Disseminated Cryptococcus with ocular cryptococcoma in a human immunodeficiency virus-negative patient.

International ophthalmology·2012
Same journal

Skin Cancer: Management of Cutaneous Melanoma.

FP essentials·2026
Same journal

Skin Cancer: Management of Actinic Keratoses and Keratinocyte Carcinomas.

FP essentials·2026
Same journal

Skin Cancer: Diagnosis.

FP essentials·2026
Same journal

Skin Cancer: Screening and Prevention.

FP essentials·2026
Same journal

Skin Cancer.

FP essentials·2026
Same journal

Obesity Management: Surgical Interventions.

FP essentials·2026
See all related articles

Related Experiment Video

Updated: Apr 10, 2026

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
05:35

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

Published on: January 19, 2024

1.7K

Hematologic Disorders: Anemia.

David Baltierra1, Tiffany Harper1, Matthew Page Jones1

  • 1West Virginia University School of Medicine Robert C. Byrd Health Sciences Center-Eastern Division, 2500 Foundation Way, Martinsburg, WV 25401.

FP Essentials
|June 17, 2015
PubMed
Summary
This summary is machine-generated.

Anemia affects up to 25% of Americans. Diagnosis involves classifying anemia by red blood cell size and conducting blood tests to guide effective treatment strategies for various anemia types.

More Related Videos

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

2.0K
Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

7.9K

Related Experiment Videos

Last Updated: Apr 10, 2026

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
05:35

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

Published on: January 19, 2024

1.7K
A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

2.0K
Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

7.9K

Area of Science:

  • Hematology
  • Internal Medicine

Background:

  • Anemia is prevalent, affecting up to 25% of the US population.
  • Normal hemoglobin levels differ based on race, sex, and age.
  • Classifying anemia by mean corpuscular volume (MCV) is crucial for diagnosis.

Purpose of the Study:

  • To outline the diagnostic approach to anemia.
  • To discuss the differential diagnosis and management of various anemia types.
  • To highlight the importance of evaluating treatment response and adherence.

Main Methods:

  • Utilizing mean corpuscular volume (MCV) for anemia classification.
  • Employing iron studies, reticulocyte count, and red blood cell distribution width (RDW).
  • Considering patient history, clinical presentation, and response to therapy.

Main Results:

  • Iron deficiency anemia, the most common microcytic type, is treated with iron therapy.
  • Normocytic anemia has a broad differential diagnosis including nutritional deficiencies, blood loss, and systemic diseases.
  • Macrocytic anemias are associated with vitamin B12/folate deficiency, alcohol, certain medications, and hematologic disorders.

Conclusions:

  • Accurate diagnosis of anemia relies on MCV classification and comprehensive blood testing.
  • Effective management requires identifying the underlying cause and appropriate therapeutic interventions.
  • Persistent anemia necessitates re-evaluation for adherence, malabsorption, bleeding, or other underlying conditions.